Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Dermawound Wound Care Venous Stasis

Last content change checked dailysee data sync status

Active ingredient
Benzocaine 1.27 g/100 g
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2014
Label revision date
December 15, 2023
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 1.27 g/100 g
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2014
Label revision date
December 15, 2023
Manufacturer
Progressive Doctors, LLC
Registration number
M017
NDC root
57554-120
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

DermaWound Professional Care® is a wound care ointment designed to provide topical pain relief for minor cuts, scrapes, and burns. It is formulated to help soothe discomfort associated with these types of injuries, making it easier for you to manage pain while your skin heals.

This ointment is part of a Venous Stasis Formula, which suggests it may be particularly beneficial for certain types of wounds. With a net weight of 6 oz. (179 g), it offers a convenient option for at-home care of minor skin injuries.

Uses

You can use this medication for the topical (applied to the skin) relief of minor pain associated with cuts, scrapes, and burns. It helps soothe discomfort and promotes healing in these common skin injuries.

There are no known teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects associated with this medication, making it a safe option for managing minor skin pain.

Dosage and Administration

To start using DermaWound, gently clean the area around the wound or ulcer. Before applying the product, check to make sure there is no excessive bleeding; remember, you should never wipe out the ulcer itself. Once the area is prepared, apply a moderate amount of DermaWound directly to the affected spot. If the wound is deeper or has "tunneling" (a channel that extends beneath the skin), you may need to pack it with DermaWound and cover the sides with additional product and sterile gauze.

If the wound produces fluid, you can add more sterile gauze to help absorb it. It's important to change the dressing two to three times a day, or as your doctor advises. For managing chronic or acute wounds, pressure sores, diabetic ulcers, surgical wounds, or indwelling catheters, you might need the guidance of a healthcare professional to ensure proper care.

What to Avoid

It's important to be aware of certain conditions and situations where you should not use this medication. If you have methemoglobinemia (a condition where your blood cannot carry enough oxygen), or if you are pregnant or breastfeeding, you should avoid using this drug. Additionally, never apply this medication to your eyes, as it is not safe for that use.

Be mindful that this medication may have potential for abuse or misuse, and it is classified as a controlled substance. If you have concerns about dependence (a condition where your body becomes reliant on a substance), please discuss them with your healthcare provider. Always follow your doctor's guidance to ensure your safety and well-being.

Side Effects

This product is intended for external use only. If you notice that your condition persists or worsens, or if you develop irritation or a rash, it’s important to stop using the product and consult a doctor. Additionally, if you find that you need to use the product for more than one week, please seek medical advice.

Before using this product, you should also talk to a doctor if you have deep or puncture wounds, animal bites, or serious burns.

Warnings and Precautions

This product is for external use only, so please avoid applying it to your eyes. If you have a condition called methemoglobinemia (a blood disorder), or if you are pregnant or breastfeeding, do not use this product.

If your condition does not improve or worsens, or if you experience any irritation or rash, stop using the product and contact your doctor. Additionally, if you find that you need to use the product for more than one week, please consult your healthcare provider.

In case of accidental swallowing, seek medical help immediately or contact a Poison Control Center. Your safety is important, so please take these precautions seriously.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there are no specific signs or symptoms listed for an overdose, you should be aware of general warning signs such as extreme drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms or feel something is wrong, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health.

Pregnancy Use

If you are pregnant or breastfeeding, it is important to avoid using this medication. The potential risks to your developing baby or nursing child are significant, and it is best to prioritize their health and safety. Always consult with your healthcare provider for guidance on safe treatment options during pregnancy and lactation.

Lactation Use

If you are breastfeeding, it is important to know that this medication should not be used while you are nursing. There are potential risks associated with its use during lactation (the period of breastfeeding), and it is advised to avoid it altogether. Always consult with your healthcare provider for guidance on safe medication options while breastfeeding to ensure the well-being of both you and your baby.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment based on your individual needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can provide the best care tailored to your needs.

Always feel free to ask questions and share all the medications and supplements you are using. This helps your provider monitor your health effectively and make informed decisions about your treatment.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 59°F and 86°F (15°C and 30°C). It's important to keep it away from heat sources and direct sunlight, as these can affect its quality. If you notice any separation of components, simply stir them to mix them back together before use.

Always handle the product with care to maintain its integrity. Following these storage and handling guidelines will help ensure that you get the most out of your device.

Additional Information

You will apply this medication topically, which means you will apply it directly to the skin. It's important to change the dressing 2 to 3 times a day or as your doctor advises. If you have any questions about how to use this medication or its effects, be sure to consult your healthcare provider for guidance.

FAQ

What is DermaWound Professional Care®?

DermaWound Professional Care® is a wound care local anesthetic ointment designed for topical pain relief of minor cuts, scrapes, and burns.

How should I use DermaWound?

Gently clean around the affected area, apply a moderate amount of DermaWound directly to the wound, and change the dressing 2 or 3 times daily or as directed by a physician.

Are there any contraindications for using DermaWound?

Do not use DermaWound if you have methemoglobinemia, are pregnant, or are lactating.

What should I do if I experience irritation or rash while using DermaWound?

Stop using DermaWound and ask a doctor if irritation or rash appears, or if the condition persists or worsens.

Can I use DermaWound on deep or puncture wounds?

You should ask a doctor before using DermaWound on deep or puncture wounds, animal bites, or serious burns.

What should I do if DermaWound is swallowed?

If swallowed, get medical help or contact a Poison Control Center right away.

How should I store DermaWound?

Store DermaWound at 59°-86°F (15-30°C) and avoid heat and direct sunlight.

Is DermaWound safe for children?

Keep DermaWound out of reach of children, and consult a doctor for use in pediatric patients.

Packaging Info

Below are the non-prescription pack sizes of Dermawound Wound Care Venous Stasis (benzocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dermawound Wound Care Venous Stasis.
Details

Drug Information (PDF)

This file contains official product information for Dermawound Wound Care Venous Stasis, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

DermaWound Professional Care® is a wound care local anesthetic ointment formulated specifically for venous stasis. The product is presented in a net weight of 6 oz. (179 g).

Uses and Indications

This drug is indicated for the topical relief of pain associated with minor cuts, scrapes, and burns.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals should follow these guidelines for the application of DermaWound. Prior to application, the affected area must be gently cleaned, ensuring that no excessive bleeding is present. It is important to avoid wiping out the ulcer during this evaluation.

A moderate amount of DermaWound should be applied directly to the affected area. For deeper or "tunneling" wounds, it may be necessary to pack the wound and/or coat the sides with additional DermaWound, followed by the application of sterile gauze. If exudates are present, additional sterile gauze may be applied to absorb them.

Dressing changes should occur 2 to 3 times daily or as directed by a physician. The management of chronic and acute wound care, including pressure sores, diabetic ulcers, surgical wounds, and indwelling catheters, may require supervision from a healthcare professional.

Contraindications

Use is contraindicated in patients with methemoglobinemia due to the risk of exacerbating this condition. Additionally, the product should not be used in pregnant or lactating individuals, as safety has not been established in these populations.

Furthermore, application in the eyes is contraindicated to prevent potential harm or adverse effects.

Warnings and Precautions

For external use only. This product is contraindicated for application in the eyes and should not be used by individuals with methemoglobinemia. Additionally, it is not recommended for use during pregnancy or lactation.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition for which the product is being used persists or worsens. Patients should also seek medical advice if any irritation or rash develops during use. If the product is required for more than one week, it is essential to stop use and contact a healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

For external use only. Patients should stop using the product and consult a doctor if the condition persists or worsens, if irritation or rash appears, or if there is a need to use the product for more than one week. Additionally, it is advised to seek medical advice before use in cases of deep or puncture wounds, animal bites, or serious burns.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dermawound Wound Care Venous Stasis (benzocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dermawound Wound Care Venous Stasis.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are lactating should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and there is insufficient data to determine its safety for fetal outcomes. Healthcare professionals are advised to consider alternative treatments for women who are pregnant or breastfeeding to avoid any potential harm to the fetus or infant.

Lactation

Lactating mothers are advised against the use of this medication. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of specific antidotes or treatments should be considered based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or lactating individuals due to potential teratogenic effects. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be used in the eyes.

Patients should be cautioned against using the product if they have methemoglobinemia, and they should be made aware that it is contraindicated during pregnancy or lactation. Providers should encourage patients to stop using the product and consult a doctor if their condition persists or worsens, or if they experience any irritation or rash.

Additionally, patients should be instructed to discontinue use and seek medical advice if they find it necessary to use the product for more than one week. Healthcare providers should also recommend that patients consult a doctor before using the product in cases of deep or puncture wounds, animal bites, or serious burns.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a temperature range of 59° to 86°F (15° to 30°C). Care should be taken to avoid exposure to heat and direct sunlight to maintain product integrity. In the event that separation occurs, it is recommended to stir the product before use to ensure uniformity.

Additional Clinical Information

The medication is administered topically, with a recommended dressing change occurring 2 to 3 times daily or as directed by a physician. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dermawound Wound Care Venous Stasis, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Dermawound Wound Care Venous Stasis, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.